Forte Capital LLC ADV Sells 657 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Forte Capital LLC ADV lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 35,646 shares of the medical equipment provider's stock after selling 657 shares during the quarter. Intuitive Surgical accounts for approximately 2.1% of Forte Capital LLC ADV's investment portfolio, making the stock its 11th largest position. Forte Capital LLC ADV's holdings in Intuitive Surgical were worth $17,654,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Norges Bank bought a new stake in Intuitive Surgical in the fourth quarter valued at approximately $2,401,493,000. GAMMA Investing LLC boosted its holdings in Intuitive Surgical by 54,010.7% in the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after acquiring an additional 3,022,979 shares during the last quarter. Capital Research Global Investors boosted its holdings in Intuitive Surgical by 25.5% in the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock valued at $1,764,904,000 after acquiring an additional 687,906 shares during the last quarter. Northern Trust Corp boosted its holdings in Intuitive Surgical by 15.8% in the fourth quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock valued at $1,889,126,000 after acquiring an additional 494,496 shares during the last quarter. Finally, Vanguard Group Inc. boosted its holdings in Intuitive Surgical by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock valued at $16,813,478,000 after acquiring an additional 360,591 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 188 shares of the business's stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total value of $96,991.08. Following the transaction, the executive vice president directly owned 5,224 shares of the company's stock, valued at approximately $2,695,113.84. The trade was a 3.47% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president directly owned 907 shares of the company's stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Up 0.5%

NASDAQ ISRG traded up $2.46 on Friday, reaching $518.62. The company had a trading volume of 1,903,997 shares, compared to its average volume of 1,685,138. The stock has a market capitalization of $185.88 billion, a P/E ratio of 76.04, a P/E/G ratio of 5.44 and a beta of 1.64. The company's fifty day moving average is $536.26 and its 200 day moving average is $536.13. Intuitive Surgical, Inc. has a 52-week low of $413.82 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same period in the prior year, the firm posted $1.50 EPS. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently commented on ISRG. BTIG Research set a $566.00 target price on Intuitive Surgical and gave the company a "buy" rating in a report on Monday. Truist Financial cut their price target on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Royal Bank Of Canada cut their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Piper Sandler cut their price target on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a report on Wednesday, April 23rd. Finally, Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday, June 5th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $592.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.